Tag
A 3-year-old boy with metastatic hepatoblastoma achieved complete cancer regression after two doses of experimental CAR T cell therapy, administered outpatient without systemic toxicity.
Researchers are testing CAR T cell therapy, originally designed for cancer, as a treatment for autoimmune diseases like multiple sclerosis, aiming to reset the immune system. The article follows a patient who received the experimental treatment.